- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05624450
Effekt og sikkerhet av tozorakimab hos pasienter innlagt på sykehus for viral lungeinfeksjon som krever ekstra oksygen (TILIA)
En fase III, multisenter, randomisert, dobbeltblind, parallellgruppe, placebokontrollert studie for å evaluere effektiviteten og sikkerheten til Tozorakimab (MEDI3506) hos pasienter innlagt på sykehus for viral lungeinfeksjon som krever ekstra oksygen
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression to IMV/ECMO.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Fase 3
Kontakter og plasseringer
Studiekontakt
- Navn: AstraZeneca Clinical Study Information Center
- Telefonnummer: 1-877-240-9479
- E-post: information.center@astrazeneca.com
Studiesteder
-
-
-
Buenos Aires, Argentina, C1180AAV
- Rekruttering
- Research Site
-
Buenos Aires, Argentina, C1046
- Fullført
- Research Site
-
Buenos Aires, Argentina, C1120AAF
- Fullført
- Research Site
-
CABA, Argentina, C1221ADC
- Fullført
- Research Site
-
CABA, Argentina, C1425EOE
- Tilbaketrukket
- Research Site
-
La Plata, Argentina, B1900AVG
- Rekruttering
- Research Site
-
Mar del Plata, Argentina, B7600GWV
- Fullført
- Research Site
-
Munro, Argentina, B1605FRE
- Rekruttering
- Research Site
-
Rosario, Argentina, S2000CVB
- Fullført
- Research Site
-
-
-
-
-
Adelaide, Australia, 5000
- Rekruttering
- Research Site
-
Bedford Park, Australia, 5042
- Rekruttering
- Research Site
-
New Lambton Heights, Australia, 2305
- Fullført
- Research Site
-
Port Macquarie, Australia, 2444
- Rekruttering
- Research Site
-
South Brisbane, Australia, 4101
- Rekruttering
- Research Site
-
-
-
-
-
Kortrijk, Belgia, 8500
- Rekruttering
- Research Site
-
Ottignies, Belgia, 1340
- Rekruttering
- Research Site
-
Roeselare, Belgia, 8800
- Rekruttering
- Research Site
-
Yvoir, Belgia, 5530
- Rekruttering
- Research Site
-
-
-
-
-
Belo Horizonte, Brasil, 30150-221
- Tilbaketrukket
- Research Site
-
Campinas, Brasil, 13060-803
- Rekruttering
- Research Site
-
Caxias do Sul, Brasil, 95070-560
- Rekruttering
- Research Site
-
Curitiba, Brasil, 80215-901
- Fullført
- Research Site
-
Curitiba, Brasil, 80730-150
- Fullført
- Research Site
-
Indaiatuba, Brasil, 13331-501
- Fullført
- Research Site
-
Jaú, Brasil, 17201-130
- Rekruttering
- Research Site
-
Natal, Brasil, 59025-050
- Rekruttering
- Research Site
-
Niterói, Brasil, 24020-096
- Tilbaketrukket
- Research Site
-
Passo Fundo, Brasil, 99010-260
- Rekruttering
- Research Site
-
Porto Alegre, Brasil, 90020-090
- Fullført
- Research Site
-
Porto Alegre, Brasil, 90610-001
- Rekruttering
- Research Site
-
Recife, Brasil, 50070-070
- Tilbaketrukket
- Research Site
-
Ribeirão Preto, Brasil, 14049-901
- Tilbaketrukket
- Research Site
-
Rio de Janeiro, Brasil, 21040-900
- Rekruttering
- Research Site
-
Salvador, Brasil, 40170-130
- Fullført
- Research Site
-
São Caetano do Sul, Brasil, 09521-160
- Rekruttering
- Research Site
-
São José do Rio Preto, Brasil, 15090-000
- Rekruttering
- Research Site
-
São Paulo, Brasil, 04004-030
- Tilbaketrukket
- Research Site
-
São Paulo, Brasil, 09323-900
- Fullført
- Research Site
-
-
-
-
-
Montana, Bulgaria, 3400
- Tilbaketrukket
- Research Site
-
Pernik, Bulgaria, 2300
- Suspendert
- Research Site
-
Pleven, Bulgaria, 5800
- Suspendert
- Research Site
-
Rousse, Bulgaria, 7002
- Suspendert
- Research Site
-
Sofia, Bulgaria, 1407
- Tilbaketrukket
- Research Site
-
Sofia, Bulgaria, 1431
- Tilbaketrukket
- Research Site
-
Sofia, Bulgaria, 1000
- Tilbaketrukket
- Research Site
-
Sofia, Bulgaria, 1154
- Tilbaketrukket
- Research Site
-
Sofia, Bulgaria, 1606
- Suspendert
- Research Site
-
Varna, Bulgaria, 9010
- Tilbaketrukket
- Research Site
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 1N4
- Rekruttering
- Research Site
-
-
British Columbia
-
New Westminster, British Columbia, Canada, V3L 3W7
- Tilbaketrukket
- Research Site
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R2H 2A6
- Tilbaketrukket
- Research Site
-
Winnipeg, Manitoba, Canada, R3A 1R9
- Tilbaketrukket
- Research Site
-
Winnipeg, Manitoba, Canada, R3J 3M7
- Tilbaketrukket
- Research Site
-
-
Ontario
-
Brampton, Ontario, Canada, L6R 3J9
- Rekruttering
- Research Site
-
Ottawa, Ontario, Canada, K1H 8L6
- Rekruttering
- Research Site
-
Ottawa, Ontario, Canada, K1Y 4E9
- Rekruttering
- Research Site
-
Toronto, Ontario, Canada, M4N 3M5
- Rekruttering
- Research Site
-
-
Quebec
-
Lévis, Quebec, Canada, G6V 3Z1
- Rekruttering
- Research Site
-
Montreal, Quebec, Canada, H2X 3E4
- Rekruttering
- Research Site
-
Montreal, Quebec, Canada, H1T 2M4
- Rekruttering
- Research Site
-
Montreal, Quebec, Canada, H2W 1S6
- Rekruttering
- Research Site
-
Québec, Quebec, Canada, G1V 4G5
- Rekruttering
- Research Site
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7N 0W8
- Rekruttering
- Research Site
-
-
-
-
-
Bogota DC, Colombia, 111121
- Tilbaketrukket
- Research Site
-
Floridablanca, Colombia, 681004
- Fullført
- Research Site
-
Medellín, Colombia, 050021
- Fullført
- Research Site
-
Soledad, Colombia, 083001
- Fullført
- Research Site
-
Villavicencio, Colombia, 500001
- Fullført
- Research Site
-
-
-
-
-
Aalborg, Danmark, 9000
- Rekruttering
- Research Site
-
Aarhus N, Danmark, 8200
- Rekruttering
- Research Site
-
Copenhagen, Danmark, 2400
- Rekruttering
- Research Site
-
Copenhagen Ø, Danmark, 2100
- Rekruttering
- Research Site
-
Herning, Danmark, 7400
- Rekruttering
- Research Site
-
Hillerød, Danmark, 3400
- Rekruttering
- Research Site
-
Hvidovre, Danmark, 2650
- Rekruttering
- Research Site
-
Kolding, Danmark, 6000
- Rekruttering
- Research Site
-
Odense C, Danmark, 5000
- Rekruttering
- Research Site
-
Vejle, Danmark, 7100
- Rekruttering
- Research Site
-
-
-
-
-
Alexandria, Egypt, 21131
- Tilbaketrukket
- Research Site
-
Cairo, Egypt, 11561
- Tilbaketrukket
- Research Site
-
Cairo, Egypt, 11566
- Tilbaketrukket
- Research Site
-
New Cairo, Egypt, 11566
- Tilbaketrukket
- Research Site
-
-
-
-
-
Cebu, Filippinene, 6000
- Fullført
- Research Site
-
Iloilo City, Filippinene
- Rekruttering
- Research Site
-
Manila, Filippinene, 1000
- Rekruttering
- Research Site
-
Quezon City, Filippinene, 1100
- Tilbaketrukket
- Research Site
-
Quezon City, Filippinene, 1109
- Fullført
- Research Site
-
-
-
-
Alabama
-
Birmingham, Alabama, Forente stater, 35233
- Har ikke rekruttert ennå
- Research Site
-
Mobile, Alabama, Forente stater, 36608
- Rekruttering
- Research Site
-
-
Arizona
-
Phoenix, Arizona, Forente stater, 85013
- Tilbaketrukket
- Research Site
-
Phoenix, Arizona, Forente stater, 85008
- Fullført
- Research Site
-
Tucson, Arizona, Forente stater, 85719
- Rekruttering
- Research Site
-
-
California
-
Chula Vista, California, Forente stater, 91911
- Tilbaketrukket
- Research Site
-
Fresno, California, Forente stater, 93701
- Rekruttering
- Research Site
-
La Mesa, California, Forente stater, 91942
- Tilbaketrukket
- Research Site
-
Los Angeles, California, Forente stater, 90027
- Tilbaketrukket
- Research Site
-
Newport Beach, California, Forente stater, 92663
- Rekruttering
- Research Site
-
Torrance, California, Forente stater, 90505
- Rekruttering
- Research Site
-
-
Colorado
-
Colorado Springs, Colorado, Forente stater, 80909
- Rekruttering
- Research Site
-
Denver, Colorado, Forente stater, 80206
- Tilbaketrukket
- Research Site
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forente stater, 20037
- Rekruttering
- Research Site
-
-
Florida
-
Bradenton, Florida, Forente stater, 34209
- Tilbaketrukket
- Research Site
-
Bradenton, Florida, Forente stater, 34209
- Fullført
- Research Site
-
Gainesville, Florida, Forente stater, 32611
- Rekruttering
- Research Site
-
Jacksonville, Florida, Forente stater, 32224
- Rekruttering
- Research Site
-
Lakeland, Florida, Forente stater, 33805
- Rekruttering
- Research Site
-
Miami, Florida, Forente stater, 33144
- Tilbaketrukket
- Research Site
-
South Pasadena, Florida, Forente stater, 33707
- Fullført
- Research Site
-
St. Petersburg, Florida, Forente stater, 33709
- Tilbaketrukket
- Research Site
-
Tampa, Florida, Forente stater, 33617
- Rekruttering
- Research Site
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30322
- Tilbaketrukket
- Research Site
-
-
Idaho
-
Boise, Idaho, Forente stater, 83702
- Rekruttering
- Research Site
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60612
- Fullført
- Research Site
-
Elmhurst, Illinois, Forente stater, 60126
- Tilbaketrukket
- Research Site
-
Evanston, Illinois, Forente stater, 60201
- Rekruttering
- Research Site
-
-
Indiana
-
Fort Wayne, Indiana, Forente stater, 46804
- Tilbaketrukket
- Research Site
-
-
Iowa
-
Iowa City, Iowa, Forente stater, 52242
- Tilbaketrukket
- Research Site
-
-
Kansas
-
Kansas City, Kansas, Forente stater, 66160
- Tilbaketrukket
- Research Site
-
-
Kentucky
-
Louisville, Kentucky, Forente stater, 40202
- Rekruttering
- Research Site
-
-
Louisiana
-
Baton Rouge, Louisiana, Forente stater, 70808
- Rekruttering
- Research Site
-
New Orleans, Louisiana, Forente stater, 70121
- Tilbaketrukket
- Research Site
-
Shreveport, Louisiana, Forente stater, 71103
- Fullført
- Research Site
-
-
Maryland
-
Annapolis, Maryland, Forente stater, 21401
- Rekruttering
- Research Site
-
Silver Spring, Maryland, Forente stater, 20910
- Fullført
- Research Site
-
-
Massachusetts
-
Springfield, Massachusetts, Forente stater, 01199
- Fullført
- Research Site
-
Worcester, Massachusetts, Forente stater, 01655
- Fullført
- Research Site
-
-
Michigan
-
Detroit, Michigan, Forente stater, 48202
- Rekruttering
- Research Site
-
Detroit, Michigan, Forente stater, 48202
- Tilbaketrukket
- Research Site
-
Royal Oak, Michigan, Forente stater, 48073
- Rekruttering
- Research Site
-
-
Minnesota
-
Saint Paul, Minnesota, Forente stater, 55101
- Rekruttering
- Research Site
-
-
Missouri
-
Columbia, Missouri, Forente stater, 65212
- Fullført
- Research Site
-
Kansas City, Missouri, Forente stater, 64108
- Rekruttering
- Research Site
-
St Louis, Missouri, Forente stater, 63110
- Rekruttering
- Research Site
-
-
New York
-
Brooklyn, New York, Forente stater, 11203
- Tilbaketrukket
- Research Site
-
Buffalo, New York, Forente stater, 14203
- Har ikke rekruttert ennå
- Research Site
-
New York, New York, Forente stater, 10016
- Tilbaketrukket
- Research Site
-
New York, New York, Forente stater, 10039
- Rekruttering
- Research Site
-
Potsdam, New York, Forente stater, 13676
- Fullført
- Research Site
-
-
North Carolina
-
Chapel Hill, North Carolina, Forente stater, 27514
- Tilbaketrukket
- Research Site
-
Durham, North Carolina, Forente stater, 27705
- Har ikke rekruttert ennå
- Research Site
-
Greenville, North Carolina, Forente stater, 27834
- Tilbaketrukket
- Research Site
-
Winston-Salem, North Carolina, Forente stater, 27157
- Rekruttering
- Research Site
-
-
Ohio
-
Cleveland, Ohio, Forente stater, 44195
- Tilbaketrukket
- Research Site
-
Columbus, Ohio, Forente stater, 43210
- Rekruttering
- Research Site
-
Toledo, Ohio, Forente stater, 43614
- Rekruttering
- Research Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forente stater, 73104
- Rekruttering
- Research Site
-
-
Oregon
-
Corvallis, Oregon, Forente stater, 97330
- Fullført
- Research Site
-
Portland, Oregon, Forente stater, 97239
- Tilbaketrukket
- Research Site
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19107
- Tilbaketrukket
- Research Site
-
Pittsburgh, Pennsylvania, Forente stater, 15213
- Har ikke rekruttert ennå
- Research Site
-
-
Rhode Island
-
Providence, Rhode Island, Forente stater, 02903
- Har ikke rekruttert ennå
- Research Site
-
Providence, Rhode Island, Forente stater, 02903
- Fullført
- Research Site
-
-
South Carolina
-
Greenville, South Carolina, Forente stater, 29605
- Rekruttering
- Research Site
-
-
South Dakota
-
Sioux Falls, South Dakota, Forente stater, 57105
- Tilbaketrukket
- Research Site
-
-
Texas
-
Amarillo, Texas, Forente stater, 79106
- Har ikke rekruttert ennå
- Research Site
-
Dallas, Texas, Forente stater, 75204
- Rekruttering
- Research Site
-
Dallas, Texas, Forente stater, 75203
- Fullført
- Research Site
-
El Paso, Texas, Forente stater, 79905
- Rekruttering
- Research Site
-
Houston, Texas, Forente stater, 77030
- Har ikke rekruttert ennå
- Research Site
-
Houston, Texas, Forente stater, 77090
- Tilbaketrukket
- Research Site
-
Houston, Texas, Forente stater, 77030
- Fullført
- Research Site
-
-
Utah
-
Salt Lake City, Utah, Forente stater, 84107
- Rekruttering
- Research Site
-
Salt Lake City, Utah, Forente stater, 84132
- Har ikke rekruttert ennå
- Research Site
-
-
Virginia
-
Charlottesville, Virginia, Forente stater, 22908
- Rekruttering
- Research Site
-
-
Wisconsin
-
Green Bay, Wisconsin, Forente stater, 54311
- Fullført
- Research Site
-
Milwaukee, Wisconsin, Forente stater, 53295
- Tilbaketrukket
- Research Site
-
-
-
-
-
Amiens, Frankrike, 80054
- Rekruttering
- Research Site
-
Angers, Frankrike, 49033
- Rekruttering
- Research Site
-
Brest, Frankrike, 29609
- Rekruttering
- Research Site
-
Créteil, Frankrike, 94000
- Rekruttering
- Research Site
-
Dijon, Frankrike, 21000
- Rekruttering
- Research Site
-
La Tronche, Frankrike, 38700
- Rekruttering
- Research Site
-
Le Coudray, Frankrike, 28630
- Rekruttering
- Research Site
-
Montpellier, Frankrike, 34295
- Rekruttering
- Research Site
-
Nantes, Frankrike, 44800
- Rekruttering
- Research Site
-
Orléans, Frankrike, 45100
- Rekruttering
- Research Site
-
Strasbourg, Frankrike, 67091
- Rekruttering
- Research Site
-
Strasbourg, Frankrike, 67098
- Fullført
- Research Site
-
Tours, Frankrike, 37000
- Rekruttering
- Research Site
-
-
-
-
-
Athens, Hellas, 12462
- Rekruttering
- Research Site
-
Athens, Hellas, 11527
- Tilbaketrukket
- Research Site
-
Exohi Thessaloniki, Hellas, 57010
- Rekruttering
- Research Site
-
Heraklion, Hellas, 71500
- Rekruttering
- Research Site
-
Ioannina, Hellas, 45500
- Rekruttering
- Research Site
-
Thessaloniki, Hellas, 57010
- Fullført
- Research Site
-
-
-
-
-
Hong Kong, Hong Kong, 999077
- Tilbaketrukket
- Research Site
-
-
-
-
-
Ahmedabad, India, 380054
- Suspendert
- Research Site
-
Ahmedabad, India, 382415
- Avsluttet
- Research Site
-
Belagavi, India, 590010
- Rekruttering
- Research Site
-
Chennai, India, 600113
- Suspendert
- Research Site
-
Dehradun, India, 248001
- Rekruttering
- Research Site
-
Gurugram, India, 122001
- Tilbaketrukket
- Research Site
-
Gūrgaon, India, 122001
- Rekruttering
- Research Site
-
Hyderabad, India, 500035
- Suspendert
- Research Site
-
Hyderabad, India, 500068
- Rekruttering
- Research Site
-
Kanpur, India, 208002
- Rekruttering
- Research Site
-
Mumbai, India, 400008
- Tilbaketrukket
- Research Site
-
New Delhi, India, 110029
- Rekruttering
- Research Site
-
New Delhi, India, 110017
- Rekruttering
- Research Site
-
New Delhi, India, 110060
- Tilbaketrukket
- Research Site
-
Pune, India, 411043
- Avsluttet
- Research Site
-
Thane, India, 401107
- Avsluttet
- Research Site
-
Vijayawada, India, 520 008
- Rekruttering
- Research Site
-
-
-
-
-
Afula, Israel, 18341
- Fullført
- Research Site
-
Ashkelon, Israel, 7830604
- Fullført
- Research Site
-
Beersheba, Israel, 8410101
- Tilbaketrukket
- Research Site
-
Haifa, Israel, 34362
- Fullført
- Research Site
-
Holon, Israel, 58100
- Rekruttering
- Research Site
-
Jerusalem, Israel, 91120
- Fullført
- Research Site
-
Petah Tikva, Israel, 4941492
- Avsluttet
- Research Site
-
Ramat Gan, Israel, 52621
- Rekruttering
- Research Site
-
Ramat Gan, Israel, 52621
- Aktiv, ikke rekrutterende
- Research Site
-
Rehovot, Israel, 76100
- Fullført
- Research Site
-
-
-
-
-
Arezzo, Italia, 52100
- Fullført
- Research Site
-
Brescia, Italia, 25123
- Fullført
- Research Site
-
Naples, Italia, 80131
- Rekruttering
- Research Site
-
Roma, Italia, 00128
- Rekruttering
- Research Site
-
Roma, Italia, 00149
- Fullført
- Research Site
-
Rozzano, Italia, 20089
- Rekruttering
- Research Site
-
Torino, Italia, 10149
- Fullført
- Research Site
-
-
-
-
-
Chiba, Japan, 260-0852
- Rekruttering
- Research Site
-
Fukuoka, Japan, 814-0180
- Rekruttering
- Research Site
-
Gifu, Japan, 502-8558
- Rekruttering
- Research Site
-
Ginowan-shi, Japan, 901-2725
- Rekruttering
- Research Site
-
Hanyu-shi, Japan, 348-8505
- Rekruttering
- Research Site
-
Hiroshima, Japan, 734-8530
- Rekruttering
- Research Site
-
Hiroshima, Japan, 734-8551
- Tilbaketrukket
- Research Site
-
Hitachi-shi, Japan, 317-0077
- Rekruttering
- Research Site
-
Isehara-shi, Japan, 259-1193
- Rekruttering
- Research Site
-
Izumisano, Japan, 598-8577
- Tilbaketrukket
- Research Site
-
Izumo-shi, Japan, 693-8501
- Rekruttering
- Research Site
-
Kamakura-shi, Japan, 247-8533
- Rekruttering
- Research Site
-
Kamogawa-shi, Japan, 296-8602
- Tilbaketrukket
- Research Site
-
Kanazawa, Japan, 920-8650
- Rekruttering
- Research Site
-
Kanazawa, Japan, 920-8641
- Tilbaketrukket
- Research Site
-
Kasuga-shi, Japan, 816-0864
- Rekruttering
- Research Site
-
Kawasaki-shi, Japan, 216-8511
- Rekruttering
- Research Site
-
Koshigaya-shi, Japan, 343-8555
- Fullført
- Research Site
-
Kumagaya-shi, Japan, 360-0197
- Fullført
- Research Site
-
Kumamoto, Japan, 860-0008
- Rekruttering
- Research Site
-
Kusatsu-shi, Japan, 525-8585
- Tilbaketrukket
- Research Site
-
Kyoto, Japan, 612-8555
- Rekruttering
- Research Site
-
Kyoto, Japan, 602-8566
- Tilbaketrukket
- Research Site
-
Maebashi, Japan, 371-0811
- Rekruttering
- Research Site
-
Meguro-ku, Japan, 152-8902
- Rekruttering
- Research Site
-
Mitaka-shi, Japan, 181-8611
- Rekruttering
- Research Site
-
Nagoya, Japan, 466-8560
- Tilbaketrukket
- Research Site
-
Nerima-ku, Japan, 179-0072
- Rekruttering
- Research Site
-
Okayama, Japan, 702-8055
- Tilbaketrukket
- Research Site
-
Okazaki-shi, Japan, 444-0827
- Rekruttering
- Research Site
-
Omuta-shi, Japan, 837-0911
- Rekruttering
- Research Site
-
Osaka, Japan, 545-8586
- Rekruttering
- Research Site
-
Osaka, Japan, 543-0035
- Rekruttering
- Research Site
-
Osaka, Japan, 534-0021
- Rekruttering
- Research Site
-
Sapporo, Japan, 062-0931
- Fullført
- Research Site
-
Sapporo, Japan, 063-0005
- Rekruttering
- Research Site
-
Shinagawa-ku, Japan, 142-8666
- Tilbaketrukket
- Research Site
-
Shinjuku-ku, Japan, 162-8655
- Fullført
- Research Site
-
Suita-shi, Japan, 565-0871
- Tilbaketrukket
- Research Site
-
Tachikawa-shi, Japan, 190-8531
- Rekruttering
- Research Site
-
Takamatsu, Japan, 760-0018
- Fullført
- Research Site
-
Urasoe-shi, Japan, 901-2132
- Rekruttering
- Research Site
-
Ureshino-shi, Japan, 843-0393
- Fullført
- Research Site
-
Yokohama, Japan, 245-8575
- Rekruttering
- Research Site
-
Yokohama, Japan, 236-0004
- Rekruttering
- Research Site
-
Yokohama, Japan, 241-0811
- Tilbaketrukket
- Research Site
-
-
-
-
-
Anyang, Kina, 455099
- Rekruttering
- Research Site
-
Beijing, Kina, 100029
- Rekruttering
- Research Site
-
Beijing, Kina
- Rekruttering
- Research Site
-
Beijing, Kina, 101199
- Rekruttering
- Research Site
-
Beijing, Kina, 100015
- Rekruttering
- Research Site
-
Changchun, Kina, 130041
- Rekruttering
- Research Site
-
Changsha, Kina, 410004
- Rekruttering
- Research Site
-
Changsha, Kina, 410015
- Rekruttering
- Research Site
-
Chengdu, Kina, 610000
- Rekruttering
- Research Site
-
Chengdu, Kina, 610072
- Rekruttering
- Research Site
-
Chongqing, Kina, 400010
- Rekruttering
- Research Site
-
Chongqing, Kina, 402160
- Har ikke rekruttert ennå
- Research Site
-
Fuyang, Kina, 236012
- Rekruttering
- Research Site
-
Guangzhou, Kina, 510180
- Rekruttering
- Research Site
-
Guangzhou, Kina, 510515
- Tilbaketrukket
- Research Site
-
Haikou, Kina, 570311
- Rekruttering
- Research Site
-
Hangzhou, Kina, 310006
- Rekruttering
- Research Site
-
Hangzhou, Kina, 310016
- Tilbaketrukket
- Research Site
-
Hefei, Kina, 230001
- Tilbaketrukket
- Research Site
-
Jinhua, Kina, 321099
- Rekruttering
- Research Site
-
Jining, Kina, 272006
- Rekruttering
- Research Site
-
Nanchang, Kina, 330006
- Rekruttering
- Research Site
-
Nanjing, Kina, 211100
- Rekruttering
- Research Site
-
Nantong, Kina, 226001
- Rekruttering
- Research Site
-
Ningbo, Kina, 315010
- Rekruttering
- Research Site
-
Qingdao, Kina, 266011
- Rekruttering
- Research Site
-
Shanghai, Kina, 200025
- Rekruttering
- Research Site
-
Shanghai, Kina, 200032
- Rekruttering
- Research Site
-
Shanghai, Kina, 201199
- Rekruttering
- Research Site
-
Shanghai, Kina, 200240
- Rekruttering
- Research Site
-
Shanghai, Kina, CN-200433
- Rekruttering
- Research Site
-
Shenzhen, Kina, 518020
- Rekruttering
- Research Site
-
Tianjin, Kina, 300050
- Rekruttering
- Research Site
-
Weifang, Kina, 261041
- Rekruttering
- Research Site
-
Wuhan, Kina, 430030
- Rekruttering
- Research Site
-
Wuhan, Kina, 430023
- Tilbaketrukket
- Research Site
-
Xinxiang, Kina, 453100
- Rekruttering
- Research Site
-
Yangzhou, Kina, 225001
- Rekruttering
- Research Site
-
Yantai, Kina, 264000
- Rekruttering
- Research Site
-
Yinchuan, Kina, 750004
- Rekruttering
- Research Site
-
Yueyang, Kina, 414000
- Rekruttering
- Research Site
-
Zhengzhou, Kina, 450000
- Rekruttering
- Research Site
-
-
-
-
-
Kota Kinabalu, Malaysia, 88200
- Fullført
- Research Site
-
Kuala Lumpur, Malaysia, 50586
- Fullført
- Research Site
-
Kuala Lumpur, Malaysia, 59100
- Fullført
- Research Site
-
Kuala Terengganu, Malaysia, 20400
- Tilbaketrukket
- Research Site
-
Kuantan, Malaysia, 25200
- Fullført
- Research Site
-
Kubang Kerian, Malaysia, 16150
- Fullført
- Research Site
-
Malacca, Malaysia, 75400
- Fullført
- Research Site
-
Petaling Jaya, Malaysia, 47500
- Fullført
- Research Site
-
Pulau Pinang, Malaysia, 10450
- Fullført
- Research Site
-
Sarawak Miri, Malaysia, 98000
- Fullført
- Research Site
-
Selangor Darul Ehsan, Malaysia, 42300
- Tilbaketrukket
- Research Site
-
Shah Alam, Malaysia, 40000
- Fullført
- Research Site
-
-
-
-
-
Aguascalientes, Mexico, 20259
- Tilbaketrukket
- Research Site
-
Guadalajara, Mexico, 44340
- Rekruttering
- Research Site
-
Guadalajara, Mexico, 44280
- Rekruttering
- Research Site
-
Mexico City, Mexico, 06720
- Rekruttering
- Research Site
-
Mexico City, Mexico, 06726
- Tilbaketrukket
- Research Site
-
Monterrey, Mexico, 64460
- Rekruttering
- Research Site
-
San Luis Potosí City, Mexico, 78250
- Rekruttering
- Research Site
-
Tlalpan, Mexico, 14050
- Tilbaketrukket
- Research Site
-
Tlalpan, Mexico, 14080
- Har ikke rekruttert ennå
- Research Site
-
Xalapa, Mexico, 91020
- Tilbaketrukket
- Research Site
-
-
-
-
-
Cusco, Peru, CUSCO 01
- Rekruttering
- Research Site
-
El Agustino, Peru, LIMA 10
- Tilbaketrukket
- Research Site
-
Lima, Peru, LIMA 31
- Rekruttering
- Research Site
-
Lima, Peru, 15131
- Har ikke rekruttert ennå
- Research Site
-
Lima, Peru, 15088
- Tilbaketrukket
- Research Site
-
Lima, Peru, LIMA 1
- Rekruttering
- Research Site
-
Lima, Peru, LIMA 01
- Tilbaketrukket
- Research Site
-
Lima, Peru, 15324
- Tilbaketrukket
- Research Site
-
Lima, Peru, LIMA 11
- Rekruttering
- Research Site
-
Lima, Peru, 15074
- Tilbaketrukket
- Research Site
-
Piura, Peru, 05
- Tilbaketrukket
- Research Site
-
-
-
-
-
Chrzanów, Polen, 32-500
- Rekruttering
- Research Site
-
Lodz, Polen, 91-347
- Avsluttet
- Research Site
-
Rzeszów, Polen, 35-241
- Tilbaketrukket
- Research Site
-
Warsaw, Polen, 01-138
- Rekruttering
- Research Site
-
Warsaw, Polen, 00-416
- Tilbaketrukket
- Research Site
-
Warsaw, Polen, 04-141
- Rekruttering
- Research Site
-
Wroclaw, Polen, 51-149
- Tilbaketrukket
- Research Site
-
Łańcut, Polen, 37-100
- Rekruttering
- Research Site
-
Łęczna, Polen, 21-010
- Rekruttering
- Research Site
-
-
-
-
-
Bayamón, Puerto Rico, 00961
- Tilbaketrukket
- Research Site
-
-
-
-
-
Bucharest, Romania, 010825
- Tilbaketrukket
- Research Site
-
Bucharest, Romania, 21105
- Fullført
- Research Site
-
Cluj-Napoca, Romania, 400000
- Fullført
- Research Site
-
Constanța, Romania, 900709
- Fullført
- Research Site
-
Iași, Romania, 700116
- Fullført
- Research Site
-
Sibiu, Romania, 550245
- Fullført
- Research Site
-
Timișoara, Romania, 300310
- Fullført
- Research Site
-
-
-
-
-
Jeddah, Saudi-Arabia, 21423
- Tilbaketrukket
- Research Site
-
Riyadh, Saudi-Arabia, 12231
- Tilbaketrukket
- Research Site
-
Riyadh, Saudi-Arabia, 11426
- Fullført
- Research Site
-
Riyadh, Saudi-Arabia, 12372
- Fullført
- Research Site
-
-
-
-
-
Bratislava, Slovakia, 82606
- Tilbaketrukket
- Research Site
-
-
-
-
-
Barcelona, Spania, 08036
- Tilbaketrukket
- Research Site
-
Barcelona, Spania, 08003
- Fullført
- Research Site
-
Madrid, Spania, 28034
- Fullført
- Research Site
-
Majadahonda, Spania, 28222
- Fullført
- Research Site
-
Málaga, Spania, 29010
- Fullført
- Research Site
-
Ourense, Spania, 32005
- Tilbaketrukket
- Research Site
-
Palma de Mallorca, Spania, 07010
- Fullført
- Research Site
-
Pamplona, Spania, 31008
- Fullført
- Research Site
-
Santander, Spania, 39008
- Fullført
- Research Site
-
Valencia, Spania, 46010
- Fullført
- Research Site
-
-
-
-
-
Bristol, Storbritannia, BS105NB
- Rekruttering
- Research Site
-
Dundee, Storbritannia, DD1 9SY
- Rekruttering
- Research Site
-
Glasgow, Storbritannia, G51 4TF
- Tilbaketrukket
- Research Site
-
Glasgow, Storbritannia, G4 0SF
- Fullført
- Research Site
-
Hampshire, Storbritannia, SO16 6YD
- Rekruttering
- Research Site
-
Huddersfield, Storbritannia, HD3 3EA
- Rekruttering
- Research Site
-
Leeds, Storbritannia, LS9 7TF
- Rekruttering
- Research Site
-
Leicester, Storbritannia, LE3 9QP
- Rekruttering
- Research Site
-
London, Storbritannia, W2 1NY
- Rekruttering
- Research Site
-
London, Storbritannia, W1T 7HA
- Rekruttering
- Research Site
-
London, Storbritannia, W6 8RF
- Tilbaketrukket
- Research Site
-
Oxford, Storbritannia, OX3 9DU
- Rekruttering
- Research Site
-
Prescot, Storbritannia, L35 5DR
- Rekruttering
- Research Site
-
Tyne and Wear, Storbritannia, NE29 8NH
- Rekruttering
- Research Site
-
Wythenshawe, Storbritannia, M23 9LT
- Tilbaketrukket
- Research Site
-
-
-
-
-
Helsingborg, Sverige, 25187
- Rekruttering
- Research Site
-
Huddinge, Sverige, 14157
- Rekruttering
- Research Site
-
Lund, Sverige, 22185
- Rekruttering
- Research Site
-
Malmö, Sverige, 20502
- Rekruttering
- Research Site
-
Solna, Sverige, 17176
- Tilbaketrukket
- Research Site
-
Stockholm, Sverige, 11861
- Rekruttering
- Research Site
-
Stockholm, Sverige, 18288
- Aktiv, ikke rekrutterende
- Research Site
-
Umeå, Sverige, 90185
- Rekruttering
- Research Site
-
Västerås, Sverige, 72189
- Fullført
- Research Site
-
-
-
-
-
Daegu, Sør -Korea, 42415
- Tilbaketrukket
- Research Site
-
Jeonju, Sør -Korea, 54907
- Tilbaketrukket
- Research Site
-
Seoul, Sør -Korea, 143-729
- Tilbaketrukket
- Research Site
-
-
-
-
-
Johannesburg, Soweto, Sør-Afrika, 2013
- Avsluttet
- Research Site
-
Observatory, Sør-Afrika, 7925
- Rekruttering
- Research Site
-
Parktown, Sør-Afrika, 2193
- Rekruttering
- Research Site
-
Westdene, Sør-Afrika, 2092
- Avsluttet
- Research Site
-
-
-
-
-
Kaohsiung City, Taiwan, 80756
- Rekruttering
- Research Site
-
Kaohsiung City, Taiwan, 81362
- Rekruttering
- Research Site
-
Taichung, Taiwan, 40447
- Rekruttering
- Research Site
-
Taichung, Taiwan, 40705
- Tilbaketrukket
- Research Site
-
Taipei, Taiwan, 112
- Rekruttering
- Research Site
-
Taipei, Taiwan, 0116
- Rekruttering
- Research Site
-
Taipei, Taiwan, 10002
- Avsluttet
- Research Site
-
Taoyuan, Taiwan, 333
- Rekruttering
- Research Site
-
Taoyuan City, Taiwan, 330
- Rekruttering
- Research Site
-
-
-
-
-
Bangkok, Thailand, 10210
- Rekruttering
- Research Site
-
Bangkok, Thailand, 10400
- Rekruttering
- Research Site
-
Bangkok, Thailand, 10700
- Rekruttering
- Research Site
-
Banphaeo, Thailand, 74120
- Rekruttering
- Research Site
-
Chiang Mai, Thailand, 50200
- Rekruttering
- Research Site
-
Khlong Luang, Thailand, 12120
- Rekruttering
- Research Site
-
Khon Kaen, Thailand, 40002
- Fullført
- Research Site
-
Muang, Thailand, 70000
- Har ikke rekruttert ennå
- Research Site
-
Muang, Thailand, 11000
- Har ikke rekruttert ennå
- Research Site
-
Phutthamonthon, Thailand, 73170
- Suspendert
- Research Site
-
Ubonratchathani, Thailand, 34000
- Tilbaketrukket
- Research Site
-
-
-
-
-
Benešov, Tsjekkia, 256 01
- Fullført
- Research Site
-
Brno, Tsjekkia, 625 00
- Fullført
- Research Site
-
Hradec Králové, Tsjekkia, 500 05
- Tilbaketrukket
- Research Site
-
Kolín, Tsjekkia, 280 02
- Rekruttering
- Research Site
-
Kyjov, Tsjekkia, 697 01
- Fullført
- Research Site
-
Mladá Boleslav, Tsjekkia, 293 01
- Fullført
- Research Site
-
Prague, Tsjekkia, 100 34
- Tilbaketrukket
- Research Site
-
Prague, Tsjekkia, 150 30
- Tilbaketrukket
- Research Site
-
Prague, Tsjekkia, 18000
- Rekruttering
- Research Site
-
-
-
-
-
Ankara, Tyrkia (Türkiye), 06800
- Suspendert
- Research Site
-
Diyarbakır, Tyrkia (Türkiye), 21280
- Rekruttering
- Research Site
-
Istanbul, Tyrkia (Türkiye), 34010
- Tilbaketrukket
- Research Site
-
Istanbul, Tyrkia (Türkiye), 34303
- Rekruttering
- Research Site
-
Istanbul, Tyrkia (Türkiye), 34899
- Rekruttering
- Research Site
-
Istanbul, Tyrkia (Türkiye), 34069
- Avsluttet
- Research Site
-
Izmir, Tyrkia (Türkiye), 35040
- Suspendert
- Research Site
-
Izmir, Tyrkia (Türkiye), 35110
- Suspendert
- Research Site
-
Malatya, Tyrkia (Türkiye), 44280
- Suspendert
- Research Site
-
Ortahisar, Tyrkia (Türkiye), 61080
- Rekruttering
- Research Site
-
İzmit, Tyrkia (Türkiye), 41000
- Suspendert
- Research Site
-
-
-
-
-
Augsburg, Tyskland, 86156
- Rekruttering
- Research Site
-
Berlin, Tyskland, 12351
- Rekruttering
- Research Site
-
Berlin, Tyskland, 10117
- Avsluttet
- Research Site
-
Cologne, Tyskland, 51109
- Rekruttering
- Research Site
-
Hamburg, Tyskland, 20246
- Fullført
- Research Site
-
Hanover, Tyskland, 30625
- Avsluttet
- Research Site
-
Kiel, Tyskland, 24105
- Rekruttering
- Research Site
-
Leverkusen, Tyskland, 51375
- Fullført
- Research Site
-
Marburg, Tyskland, 35043
- Rekruttering
- Research Site
-
Regensburg, Tyskland, 93053
- Tilbaketrukket
- Research Site
-
Rosenheim, Tyskland, 83022
- Rekruttering
- Research Site
-
Rostock, Tyskland, 18057
- Rekruttering
- Research Site
-
-
-
-
-
Balassagyarmat, Ungarn, 2660
- Fullført
- Research Site
-
Budapest, Ungarn, 1082
- Rekruttering
- Research Site
-
Budapest, Ungarn, 1121
- Fullført
- Research Site
-
Debrecen, Ungarn, 4032
- Rekruttering
- Research Site
-
Győr, Ungarn, 9024
- Fullført
- Research Site
-
Kaposvár, Ungarn, 7400
- Rekruttering
- Research Site
-
Kistarcsa, Ungarn, 2143
- Tilbaketrukket
- Research Site
-
Nyíregyháza, Ungarn, 4400
- Rekruttering
- Research Site
-
Pécs, Ungarn, 7624
- Rekruttering
- Research Site
-
-
-
-
-
Haiphong, Vietnam, 180000
- Rekruttering
- Research Site
-
Haiphong, Vietnam, 180000
- Tilbaketrukket
- Research Site
-
Hanoi, Vietnam, 100000
- Rekruttering
- Research Site
-
Ho Chi Minh City, Vietnam, 700000
- Rekruttering
- Research Site
-
Ho Chi Minh City, Vietnam, 700000
- Tilbaketrukket
- Research Site
-
Ho Chi Minh City, Vietnam
- Tilbaketrukket
- Research Site
-
Hochiminh City, Vietnam, 700000
- Rekruttering
- Research Site
-
Huế, Vietnam, 530000
- Rekruttering
- Research Site
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Adult participants ≥ 18 years old at the time of signing the informed consent form.
- Patients hospitalised with viral lung infection.
- Hypoxaemia requiring treatment with supplemental O2.
Hypoxaemia is defined as:
SpO2 ≤ 90% OR
SpO2 ≤ 92% AND one or both of the following:
Radiographic infiltrates by CXR/CT compatible with viral lung infection per investigator judgement.
Use of accessory muscles of respiration or RR (respiratory rate) > 22.
- Patient remains hypoxaemic at randomisation requiring treatment with supplemental oxygen.
Exclusion Criteria:
- Known fungal or parasitic lung infection, aspiration lung infection, lung abscess, or evidence of septic shock. Bacterial co-infection is allowed, unless, in the opinion of the investigator, bacterial infection defines the severity of the participant's condition.
- Hypoxaemia caused primarily by extrapulmonary insult or by lung injury of non-infective aetiology.
- Ongoing IMV/ECMO at randomisation.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Trippel
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Tozorakimab
Approximately 2870 participants will be randomized in a 1:1 ratio. Arm 1 (n=approximately 1435) will receive a single dose of tozorakimab. |
Single IV dose of tozorakimab on Day 1.
Andre navn:
|
|
Placebo komparator: Placebo
Approximately 2870 participants will be randomized in a 1:1 ratio. Arm 2 (n=approximately 1435) will receive matching placebo. |
Single IV dose of matching placebo on Day 1. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of participants who die or progress to Invasive Mechanical Ventilation (IMV) / Extracorporeal Membrane Oxygen (ECMO)
Tidsramme: by Day 28
|
To evaluate the effect of tozorakimab versus placebo as an add on to Standard of Care (SoC) in participants with viral lung infection requiring supplemental oxygen on the prevention of death or progression to IMV/ECMO. |
by Day 28
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of participants who die
Tidsramme: by Day 60
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on all-cause mortality. |
by Day 60
|
|
Number of days alive and outside of Intensive Care Unit (ICU)
Tidsramme: over 28 day period
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on ICU stay. |
over 28 day period
|
|
Number of days alive and free of supplemental oxygen
Tidsramme: over 28 day period
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on the duration of oxygen supplementation. |
over 28 day period
|
|
Time to death or progression to Invasive Mechanical Ventilation (IMV) / Extracorporeal Membrane Oxygen (ECMO)
Tidsramme: over 28 day and 60 day period
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on prolonging time to death or IMV/ECMO. |
over 28 day and 60 day period
|
|
Proportion of participants who die or progress to Invasive Mechanical Ventilation (IMV) / Extracorporeal Membrane Oxygen (ECMO)
Tidsramme: by Day 60
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on prolonging time to death or IMV/ECMO. |
by Day 60
|
|
Time to death (all cause)
Tidsramme: over 28 day and 60 day period
|
To evaluate the effect of Tozorakimab versus Placebo as add-on to Standard of Care (SoC) on prolonging time to death. |
over 28 day and 60 day period
|
|
Proportion of participants who die
Tidsramme: by Day 28
|
To evaluate the effect of Tozorakimab versus Placebo as add-on to Standard of Care (SoC) on prolonging time to death. |
by Day 28
|
|
Number of days alive and free of Invasive Mechanical Ventilation (IMV) / Extracorporeal Membrane Oxygen (ECMO)
Tidsramme: over 28 day and 60 day period
|
To evaluate the effect of Tozorakimab versus placebo as add-on to Standard of Care (SoC) on ventilator use. |
over 28 day and 60 day period
|
|
Number of days alive and ventilator free
Tidsramme: over 28 day and 60 day period
|
To evaluate the effect of Tozorakimab versus placebo as add-on to Standard of Care (SoC) on ventilator use. |
over 28 day and 60 day period
|
|
Proportion of participants with Intensive Care Unit (ICU) admission or death
Tidsramme: by Day 28
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on ICU admissions. |
by Day 28
|
|
Proportion of participants with Intensive Care Unit (ICU) admission or death
Tidsramme: by Day 60
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on ICU admissions. |
by Day 60
|
|
Proportion of participants alive and discharged
Tidsramme: by Day 28
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on duration of hospitalisation. |
by Day 28
|
|
Proportion of participants alive and discharged
Tidsramme: by Day 60
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on duration of hospitalisation. |
by Day 60
|
|
Time to discharge
Tidsramme: over 28 day and 60 day period
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on duration of hospitalisation. |
over 28 day and 60 day period
|
|
Time to being off supplemental oxygen
Tidsramme: over 28 day and 60 day period
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on duration of hospitalisation. |
over 28 day and 60 day period
|
|
World Health Organization (WHO) 10-category ordinal Clinical Progression Scale
Tidsramme: by Day 60
|
To evaluate the effect of tozorakimab versus placebo as add-on to Standard of Care (SoC) on clinical status as assessed by the Investigator using WHO 10-category ordinal Clinical Progression Scale (0 least severe to 10 most severe). |
by Day 60
|
|
Presence of anti-drug antibodies
Tidsramme: over 60 day period
|
To evaluate the immunogenicity (presence of tozorakimab anti-drug antibodies in blood serum) in participants with viral lung infection requiring supplemental oxygen. |
over 60 day period
|
|
Baseline serum interleukin-33/soluble Suppression of Tumorgenicity 2 (IL-33/sST2) complex levels relative to primary endpoint
Tidsramme: Day 1
|
To evaluate the use of baseline serum IL-33/sST2 complex levels (U/mL) to predict treatment response with tozorakimab versus placebo as add on to Standard of Care (SoC). |
Day 1
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Orthomyxoviridae-infeksjoner
- RNA-virusinfeksjoner
- Sykdommer i luftveiene
- Respirasjonsforstyrrelser
- Lungebetennelse, viral
- Lungebetennelse
- Coronaviridae-infeksjoner
- Nidovirales infeksjoner
- Covid-19
- Influensa, menneske
- Lungesykdommer
- Respiratorisk distress syndrom
- Infeksjoner
- Virussykdommer
- Luftveisinfeksjoner
- Coronavirus-infeksjoner
- Alvorlig akutt luftveissyndrom
Andre studie-ID-numre
- D9185C00001
- 2022-003107-15 (EudraCT-nummer)
- 2023-507031-38-00 (Registeridentifikator: CTIS)
- 2023 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal.
All request will be evaluated as per the AZ disclosure commitment:
https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure. Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.
IPD-delingstidsramme
AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
Tilgangskriterier for IPD-deling
When a request has been approved AstraZeneca will provide access to the deidentified individual patient-level data in an approved sponsored tool . Signed Data Sharing Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information. Additionally, all users will need to accept the terms and conditions of the SAS MSE to gain access. For additional details, please review the Disclosure Statements at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .